`
`Patent Owner Masimo Corporation’s
`Demonstratives For Trial Hearing
`
`January 19, 2022
`
`Apple Inc. v. Masimo Corporation
`IPR2020-01523 (Patent 8,457,703)
`
`
`
`Petitioner’s Grounds
`
`Ground 1
`
`Ground 2
`
`Ground 3
`
`Diab + Amano
`
`Diab + GK-POSITA
`
`Amano
`
`Diab + Amano + Edgar
`
`Diab + GK-POSITA + Edgar
`
`Amano + Turcott
`
`Diab + Amano + Turcott
`
`Diab + GK-POSITA + Turcott
`
`A
`
`B
`
`C
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`2
`
`
`
`Petitioner’s Grounds By Claim
`
`Claims
`
`Ground
`1A
`
`Ground
`1B
`
`Ground
`1C
`
`Ground
`2A
`
`Ground
`2B
`
`Ground
`2C
`
`Ground
`3A
`
`Ground
`3B
`
`1-3, 15-17
`
`4-7, 18
`
`9-10, 12-
`14, 20, 22-
`24
`
`11, 21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`3
`
`
`
`Reasons Grounds 1A-2C Do Not Demonstrate
`Unpatentability
`
`Petitioner fails to show:
`
`1A
`
`1B
`
`1C
`
`2A
`
`2B
`
`2C
`
`Motivation to “suspend and not execute” MAS module
`
`Diab/Amano disclose operating at lower power
`consumption level
`
`Diab/Amano compare processing characteristics to a
`predetermined threshold
`
`Diab/Amano reduces an amount of processing
`
`Diab/Turcott reduces activation of an attached sensor
`
`Motivation to combine Diab and Amano
`
`Motivation to combine Diab, Amano, and Edgar
`
`Motivation to combine Diab, Amano, and Turcott
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`4
`
`
`
`Claims 1-2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`5
`
`
`
`Independent Claim 9
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`6
`
`
`
`’703 Patent Discloses Low Power Patient Monitors
`
`“Increasingly, pulse oximeters are being utilized
`
`in portable, battery-operated
`
`applications…[that] create an increasing
`
`demand for lower power and higher
`
`performance pulse oximeters.”
`
` Ex. 1001 at 1:55-63.
`
`Based on the measurements or statistics, the
`
`monitor modifies “power consumption by, in
`
`effect, increasing or decreasing the number of
`
`input samples received and processed.”
`
` Ex. 1001 at 6:9-11.
`
`— POR 5-12.
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`7
`
`
`
`’703 Patent – Intermittently Reducing The Duty Cycle
`
`— POR 8-10; Ex. 1001, 5:61-66, Fig. 4
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`8
`
`
`
`Duty Cycle Impact on Power Consumption
`
`— POR 9-12; Ex. 1001, 8:29-42, Fig. 8
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`9
`
`
`
`Diab
`
`Assigned to Masimo
`
`Discloses methods of isolating a primary or
`
`secondary signal portion from a composite
`
`measured signal
`
` Ex. 1007 at 3:16-21, 8:65-9:4, Figs. 4-5
`
`— POR 27-28; Ex. 2001, ¶53
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`10
`
`
`
`Examiner Considered Diab
`
`— POR 15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`11
`
`— Ex. 1001, page 2
`
`
`
`Amano
`
`“Pulse wave examination apparatus, blood
`pressure monitor, pulse waveform monitor
`and pharmacological action monitor”
`
`Characterizes pulse waveform “by the
`classification in Chinese medicine”
`
`Detects motion using an acceleration
`sensor
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`12
`
`
`
`Turcott
`
`— POR 57-59
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`13
`
`— Ex. 1006, Fig. 6
`
`
`
`Claims 1-2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`14
`
`
`
`Petitioner’s Argument to Combine Diab and Amano
`
`— POR 33-41; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`15
`
`— Pet. 17; Ex. 1003, ¶54
`
`
`
`Petitioner’s Argument to Combine Diab, Amano, and Turcott
`
`— POR 61-67; Ex. 2001, ¶¶105-114; PO’s Sur-Reply 23-27
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`16
`
`— Pet. 38; Ex. 1003, ¶80
`
`
`
`“Reducing/Reduce Activation Of An Attached Sensor”
`
`— Pet. 6
`
`—POR 19-21
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`17
`
`
`
`Turcott Describes A Single, Low Duty Cycle
`
`— Ex. 1006, 11:51-59
`
`— POR 60-61; Ex. 2002, ¶¶42, 101-104; PO’s Sur-Reply 21-23
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`18
`
`
`
`Alleged Motivations to Modify Diab and Amano Based on
`Turcott
`
`Optimize signal-to-noise ratio
`
`Minimize power consumption
` Petition 38-40; Petitioner’s Reply 19.
`
`— POR 61-67; Ex. 2002, ¶¶105-114; PO’s Sur-Reply 23-27
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`19
`
`
`
`No Motivation To Combine Diab, Amano, and Turcott
`
`POSITAs interested in minimizing power consumption would have selected a
`single, low duty cycle
`
`No reason to believe Diab/Amano required signal-to-noise ratio optimization or
`further power consumption
`
`POSITA would have been discouraged from reducing activation of Diab’s
`sensors without patient protections
`
`Turcott is an invasive, implantable monitoring device
`
`Petitioner never explains how Diab would have reduced the duty cycle in real-
`time
`
`— POR 61-67; Ex. 2002, ¶¶105-114; PO’s Sur-Reply 23-27
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`20
`
`
`
`Operation of Diab’s Heart/Pulse Rate Module (410)
`
`— POR 33-41; PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`21
`
`— Ex. 1007, 49:29-32, 50:27-29, Fig. 20; see also id., 39:25-30, Fig. 14
`
`
`
`Diab’s Use of Motion
`
`—Ex. 1007, 47:52-56
`
`— POR 33-41; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`22
`
`
`
`Figure 21 Describes The Generation of The Clean Waveform
`
`— POR 33-41; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`23
`
`— Ex. 1007, 49:14-32, Fig. 21
`
`
`
`Petitioner’s Argument
`
`— PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`24
`
`— Pet. 16 (annotations in original; yellow highlighting added)
`
`
`
`Petitioner’s Reply
`
`— PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`25
`
`
`
`The Portions of Diab Cited by Petitioner
`
`—Ex. 1007, 35:43-50
`
`—Ex. 1007, 47:2-49:10
`
`— PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`26
`
`
`
`Operation of the Correlation Canceller
`
`—Ex. 1007, 4:45-50
`
`—Ex. 1007, 4:45-50
`
`— PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`27
`
`
`
`Motion Status Input
`
`— PO’s Sur-Reply 7-11; Ex. 2001, ¶¶53-59, 65-73; POR 46-47
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`28
`
`— Ex. 2001, Fig. 20
`
`
`
`Petitioner’s Reply Argument
`
`—Reply at 5; see also id., 4 (alleged “traditional filtering techniques” include
`“low pass” and “band pass” filtering.)
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`29
`
`
`
`Figure 21 Discloses the Motion Artifact Suppression Module
`
`— PO’s Sur-Reply 11-13
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`30
`
`— Ex. 2001, 48:43-49:13, Fig. 21.
`
`
`
`No Motivation to Combine Diab and Amano
`
`Alleged Motivation: reduce power consumption
` Petition 10.
`
`Reason No Motivation to Combine:
`
`Different processing algorithms that yield different outputs
`
`No indication Diab would benefit from reduced power consumption
`
`Amano is specifically designed to “suspend and not execute” certain modules
`
`Amano requires an acceleration sensor
`
`— POR 41-45; Ex. 2001, ¶¶70-73; PO’s Sur-Reply 13-15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`31
`
`
`
`Diab versus Amano’s System
`
`— Ex. 1007, Fig. 20.
`
`— Ex. 1004, Fig. 1.
`
`— POR 41-45; Ex. 2001, ¶¶61-62, 70-73; PO’s Sur-Reply 13-15
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`32
`
`
`
`Operation of the Output Filter and Spectrum Analysis Module
`
`“If motion is large, this filter
`is slowed down, if there is
`little motion or no motion,
`this filter can sample much
`faster and still maintain a
`clean valve.”
`-Ex. 1007, 50:25-27.
`
`— POR 46-48, 52-54; Ex. 2001, ¶¶74-77, 85-90;
`PO’s Sur-Reply 15-17; Ex. 1039, 68:2-72:2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`33
`
`— Ex. 2001, 50:8-14, 50:21-29, Fig. 20.
`
`
`
`Petitioner’s Argument
`
`PO’s Sur-Reply 15-17
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`34
`
`—Petitioner’s Reply at 10-11.
`
`
`
`Diab’s Method of Determining Motion
`
`— POR 48-52; Ex. 2001, ¶¶79-84; PO’s Sur-Reply 18-20
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`35
`
`— Ex. 1007, 47:43-47, Fig. 20
`
`
`
`Petitioner’s Reply Argument
`
`— Petitioner’s Reply 14.
`
`—PO’s Sur-Reply 18-20
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`36
`
`
`
`Edgar
`
`— Ex. 1005, 3:58-4:6
`
`— POR 55-56; Ex. 2001, ¶¶91-93
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`37
`
`
`
`Reasons Grounds 3A-3B Do Not Demonstrate
`Unpatentability
`
`Petitioner fails to show:
`
`3A
`
`3B
`
`Amano compares processing characteristics to a predetermined threshold
`
`Amano determines measurement values for one or more physiological parameters
`
`Amano/Turcott reduces activation of an attached sensor or reduced duty cycle
`
`Motivation to combine Amano Turcott
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`38
`
`
`
`Claims 1-2
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`39
`
`
`
`Alleged Motivations to Modify Amano Based on Turcott
`
`Optimize signal-to-noise ratio
`
`Minimize power consumption
` Petition 64-66; Petitioner’s Reply 25-27.
`
`— POR 61-67; Ex. 2002, ¶¶105-114; PO’s Sur-Reply 23-27
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`40
`
`— Pet. 64.
`
`
`
`No Motivation to Combine Amano and Turcott
`
`POSITAs interested in minimizing power consumption would have selected a
`single, low duty cycle
`
`Amano already provides a solution to signal-to-noise ratio and power
`consumption and Petitioner provides no evidence the solution is ineffective
`
`Petitioner never explains why a POSITA would have been motivated to further
`optimize Amano
`
`POSITA would have been discouraged from reducing activation of
`Richardson’s sensors without patient protections
`
`Petitioner never explains how reducing activation of Amano’s sensor would
`optimize the signal-to-noise ratio and reduce power consumption
`
`— POR 75-79; Ex. 2001, ¶¶130-136; PO’s Sur-Reply 29-31
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`41
`
`
`
`Petitioner Relies on Amano’s Acceleration Sensor in
`Grounds 3A-3B
`
`— Pet. 50
`
`— PO’s Sur-Reply 23-24
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`42
`
`— Ex. 1004, 21:9-12, Fig. 1
`
`
`
`Petitioner’s Constructions of “Processing Characteristics”
`
`“In Ground 1A, these limitations are rendered obvious under a limiting
`interpretation requiring ‘processing characteristics’ to be obtained
`from a signal provided by a photodetector.’”
`
`— Pet. 50; Ex. 1003, ¶97; Ex. 2003, 121:17-122:21
`
`“Amano [Grounds 3A-3B] teaches these limitations based on an
`alternative non-limiting interpretation of ‘processing characteristics’
`that is met by Amano’s acceleration sensor output.”
`
`— Pet. 51; Ex. 1003, ¶98; Ex. 2003, 133:1-9
`
`— POR 21-23; PO’s Sur-Reply 2-4
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`43
`
`
`
`Petitioner’s “Limiting” Construction Is Correct
`
`Correct construction: “Processing
`characteristics are determined from a
`signal received from one or more
`detectors configured to detect light.”
` POR 23; Ex. 2001, ¶¶44-49.
`
`Claims require receiving at least one
`signal “from one or more detectors
`configured to detect said light after
`attenuation by said tissue”
` POR 24-25; Ex 2001, ¶46.
`
`— POR 23-27; Ex. 2001, ¶¶43-49; PO’s Sur-Reply 4-7
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`44
`
`
`
`Petitioner’s Reply Arguments
`
`— PO’s Sur-Reply 4-7
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`45
`
`— Petitioner’s Reply 1-3.
`
`
`
`“Power Consumption Estimate” Determination
`
`— PO’s Sur-Reply 5-6
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`46
`
`— Ex. 1001, Fig. 4.
`
`
`
`Amano Pulse Waveform Determinations
`
`— Ex. 1004, 1:41-45.
`
`— Ex. 1004, 23:4-9.
`
`— POR 71-72; PO’s Sur-Reply 27-28
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`47
`
`
`
`Petitioner’s Reply Argument
`
`— Petitioner’s Reply 24.
`
`— PO’s Sur-Reply 27-28
`
`DEMONSTRATIVE EXHIBIT – NOT EVIDENCE
`
`48
`
`